FDFriso M. C. Delemarre

Friso M. C. Delemarre

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Friso M. C. Delemarre has a total of 282 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • 472: Patient decision aid with individual risk estimation: an effective tool in choosing the mode of delivery after cesarean section

    by Emy Vankan, Ellen Schoorel, Sander van Kuijk, Robert Aardenburg, Friso Delemarre, Carmen Dirksen, Ivo van Dooren, Simone Kuppens, Anneke Kwee, Josje Langenveld, et al.


  • Open Access

    Economic analysis of use of pessary to prevent preterm birth in women with multiple pregnancy (ProTWIN trial)

    by S. M. S. Liem, G. J. van Baaren, F. M. C. Delemarre, I. M. Evers, G. Kleiverda, A. J. van Loon, J. Langenveld, N. Schuitemaker, J. M. Sikkema, B. C. Opmeer, et al.

    Objective To assess the cost-effectiveness of a cervical pessary to prevent preterm delivery in women with a multiple pregnancy. Methods The study design comprised an economic analysis of data from a randomized clinical trial evaluating cervical pessaries (ProTWIN). Women with a multiple pregnancy were included and an economic evaluation was performed from a societal perspective. Costs were estimated between the time of randomization and 6 weeks postpartum. The prespecified subgroup of women with a cervical length (CL) < 25th centile (< 38 mm) was analyzed separately. The primary endpoint was poor perinatal outcome occurring up to 6 weeks postpartum. Direct medical costs and health outcomes were estimated and incremental cost-effectiveness ratios for costs to prevent one poor outcome were calculated. Results Mean costs in the pessary group (n = 401) were €21 783 vs €21 877 in the group in which no pessary was used (n = 407) (difference, −€94; 95% CI, −€5975 to €5609). In the prespecified subgroup of women with a CL < 38 mm we demonstrated a significant reduction in poor perinatal outcome (12% vs 29%; RR, 0.40; 95% CI, 0.19–0.83). Mean costs in the pessary group (n = 78) were €25 141 vs €30 577 in the no-pessary group (n = 55) (difference, −€5436 (95% CI, −€11 001 to €1456). In women with a CL < 38 mm, pessary treatment was the dominant strategy (more effective and less costly) with a probability of 94%. Conclusion Cervical pessaries in women with a multiple pregnancy involve costs comparable to those in women without pessary treatment. However, in women with a CL < 38 mm, treatment with a cervical pessary appears to be highly cost-effective. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd


  • Open Access

    Predicting successful intended vaginal delivery after previous caesarean section: external validation of two predictive models in a Dutch nationwide registration‐based cohort with a high intended vaginal delivery rate

    by Enc Schoorel, S Melman, Smj van Kuijk, Wa Grobman, A Kwee, Bwj Mol, Jg Nijhuis, Ljm Smits, R Aardenburg, K de Boer, et al.

    Objective: To externally validate two models from the USA (entry‐to‐care [ETC] and close‐to‐delivery [CTD]) that predict successful intended vaginal birth after caesarean (VBAC) for the Dutch population.Design: A nationwide registration‐based cohort study.Setting: Seventeen hospitals in the Netherlands.Population: Seven hundred and sixty‐three pregnant women, each with one previous caesarean section and a viable singleton cephalic pregnancy without a contraindication for an intended VBAC.Methods: The ETC model comprises the variables maternal age, prepregnancy body mass index (BMI), ethnicity, previous vaginal delivery, previous VBAC and previous nonprogressive labour. The CTD model replaces prepregnancy BMI with third‐trimester BMI and adds estimated gestational age at delivery, hypertensive disease of pregnancy, cervical examination and induction of labour. We included consecutive medical records of eligible women who delivered in 2010. For validation, individual probabilities of women who had an intended VBAC were calculated.Main outcome measures: Discriminative performance was assessed with the area under the curve (AUC) of the receiver operating characteristic and predictive performance was assessed with calibration plots and the Hosmer–Lemeshow (H‐L) statistic.Results: Five hundred and fifteen (67%) of the 763 women had an intended VBAC; 72% of these (371) had an actual VBAC. The AUCs of the ETC and CTD models were 68% (95% CI 63–72%) and 72% (95% CI 67–76%), respectively. The H‐L statistic showed a P‐value of 0.167 for the ETC model and P = 0.356 for the CTD model, indicating no lack of fit.Conclusion: External validation of two predictive models developed in the USA revealed an adequate performance within the Dutch population.


  • Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial

    by Parvin Tajik, Linda van Wyk, Kim E. Boers, Saskia le Cessie, Mohammad Hadi Zafarmand, Frans Roumen, Joris A.M. van der Post, Martina Porath, Maria G. van Pampus, Marc E.A. Spaanderdam, et al.


  • Open Access

    Vaginal birth after a caesarean section: the development of a Western European population‐based prediction model for deliveries at term

    by Enc Schoorel, Smj van Kuijk, S Melman, Jg Nijhuis, Ljm Smits, R Aardenburg, K de Boer, Fmc Delemarre, Im van Dooren, Mtm Franssen, et al.

    Objective: To develop and internally validate a model that predicts the outcome of an intended vaginal birth after caesarean (VBAC) for a Western European population that can be used to personalise counselling for deliveries at term.Design: Registration‐based retrospective cohort study.Setting: Five university teaching hospitals, seven non‐university teaching hospitals, and five non‐university non‐teaching hospitals in the Netherlands.Population: A cohort of 515 women with a history of one caesarean section and a viable singleton pregnancy, without a contraindication for intended VBAC, who delivered at term.Methods: Potential predictors for a vaginal delivery after caesarean section were chosen based on literature and expert opinions. We internally validated the prediction model using bootstrapping techniques.Main outcome measures: Predictors for VBAC. For model validation, the area under the receiver operating characteristic curve (AUC) for discriminative capacity and calibration‐per‐risk‐quantile for accuracy were calculated.Results: A total of 371 out of 515 women had a VBAC (72%). Variables included in the model were: estimated fetal weight greater than the 90th percentile in the third trimester; previous non‐progressive labour; previous vaginal delivery; induction of labour; pre‐pregnancy body mass index; and ethnicity. The AUC was 71% (95% confidence interval, 95% CI = 69–73%), indicating a good discriminative ability. The calibration plot shows that the predicted probabilities are well calibrated, especially from 65% up, which accounts for 77% of the total study population.Conclusion: We developed an appropriate Western European population‐based prediction model that is aimed to personalise counselling for term deliveries.


  • Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial)

    by Sylvia M.C. Vijgen, Kim E. Boers, Brent C. Opmeer, Denise Bijlenga, Dick J. Bekedam, Kitty W.M. Bloemenkamp, Karin de Boer, Henk A. Bremer, Saskia le Cessie, Friso M.C. Delemarre, et al.


  • Open Access

    SIMPLE: implementation of recommendations from international evidence-based guidelines on caesarean sections in the Netherlands. Protocol for a controlled before and after study

    by Sonja Melman, Ellen Nc Schoorel, Carmen Dirksen, Anneke Kwee, Luc Smits, Froukje de Boer, Madelaine Jonkers, Mallory D Woiski, Ben Willem J Mol, Johannes Pr Doornbos, et al.

    Caesarean section (CS) rates are rising worldwide. In the Netherlands, the most significant rise is observed in healthy women with a singleton in vertex position between 37 and 42 weeks gestation, whereas it is doubtful whether an improved outcome for the mother or her child was obtained. It can be hypothesized that evidence-based guidelines on CS are not implemented sufficiently.


  • 780: Analysis of current Dutch practice on cesarean deliveries

    by Sonja Melman, Ellen Schoorel, Francis Vrouenraets, Anneke Kwee, Maureen Franssen, Ellen Smid-Koopman, Mallory Woiski, Ben Willem Mol, Hans Doornbos, Harry Visser, et al.

  • Neonatal Morbidity After Induction Vs Expectant Monitoring in Intrauterine Growth Restriction at Term

    by Kim E. Boers, Linda van Wyk, Joris A.M. van der Post, Anneke Kwee, Maria G. van Pampus, Marc E.A. Spaanderdam, Johannes J. Duvekot, Henk A. Bremer, Friso M.C. Delemarre, Kitty W.M. Bloemenkamp, et al.

    The Disproportionate Intrauterine Growth Intervention Trial at Term (DIGITAT) was a randomized controlled trial that prospectively observed children with suspected intrauterine growth restriction (IUGR) at term. DIGITAT was designed to investigate whether induction of labor for pregnancies with suspected IUGR beyond 36 weeks of gestation reduced neonatal morbidity and mortality compared with an expectant approach with fetal and maternal surveillance. Data from that trial showed no significant differences between the 2 approaches in primary fetal outcomes (a composite of perinatal death, abnormal umbilical arterial cord pH and Apgar scores or admission to neonatal intensive care unit as well as comparable operative delivery rates. However, more children in the induction group than in the expectant group were admitted to an intermediate level of care (48% vs 36%). It was possible that this difference in admissions was due to complications of late prematurity because children in the induction group were born, on average, 10 days earlier than did those in the expectant group. It also seemed possible that the difference was not due to clinically relevant morbidity but was associated with policies for admission to intermediate levels of care related to prematurity. The present study performed secondary analysis of the DIGITAT data to resolve these 2 competing explanations. The net effect of the 2 policies on neonatal morbidity was studied in detail using the Morbidity Assessment Index for Newborns (MAIN) score, a validated outcome measure for neonatal morbidity. Babies born to mothers with suspected IUGR were randomized to either induction (n = 308) or expectant monitoring (n = 315). There were no differences between the induction and expectant group in mean MAIN scores or in MAIN morbidity categories. Neonatal admissions were lower in both groups after 38 weeks of pregnancy than before 38 weeks. This finding suggests that a policy of induction does not increase short-term neonatal morbidity. Moreover, the data show that, when induction for near-term growth restriction is considered because of possible stillbirth, it may be reasonable to delay delivery until 38 weeks.


  • Open Access

    Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study

    by Brenda M Kazemier, Caroline Schneeberger, Esteriek De Miranda, Aleid Van Wassenaer, Patrick M Bossuyt, Tatjana E Vogelvang, Frans Jl Reijnders, Friso MC Delemarre, Corine Jm Verhoeven, Martijn A Oudijk, et al.

    The prevalence of asymptomatic bacteriuria (ASB) in pregnancy is 2-10% and is associated with both maternal and neonatal adverse outcomes as pyelonephritis and preterm delivery. Antibiotic treatment is reported to decrease these adverse outcomes although the existing evidence is of poor quality.